Bayer-Monsanto merger reflects larger trends in global agrochemical industry

Monsanto Bayer x

The progress of the Bayer-Monsanto mega-takeover, which [recently] secured regulatory approval from European Union (EU) competition authorities, is only the most recent manifestation of a wider trend of structural transformation in the global agrochemical industry.

[F]ar-reaching developments such as climate change and a rapidly growing human population have instilled the agrochemical industry with widespread urgency to find solutions to related challenges. Against a backdrop of downward pressure on the global prices of seeds and agrochemicals, industry consolidation has been one of the logical outcomes of such considerations.

If Bayer’s bet on a long-term recovery in agrochemical prices due to rapid population growth is successful, the company stands to be handsomely rewarded for its pivot from being a mixed chemical-pharmaceutical company to a more specialized leader in the subfield of biotechnology. A key rationale behind Bayer’s takeover bid in this context is to gain access to Monsanto’s “digital farming” products.

According to Monsanto CEO Hugh Grant, together, the two firms could hereby become “innovation drivers” helping farmers to cope with new pressures resulting from structural transformation in the agricultural sector.

Read full, original post: News Analysis: Bayer takeover of Monsanto highlights tectonic shifts in global agrochemical industry

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.noReviewsLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-07-30-at-3.07.42-PM
Controversy over WNBA star Sophie Cunningham’s comment opposing trans females in women’s sports reinvigorates the culture wars
leeteam
How Kennedy and his family could pocket millions from Merck’s $50 million vaccine injury settlement that he oversaw
ChatGPT-Image-Jul-10-2026-12_21_03-PM
Viewpoint: Is there new evidence that the animal deworming drug ivermectin decreases the risk of Covid and cancer? Don’t waste your money.
Screenshot-2026-07-30-at-2.30.35-PM
Climate scientists claim conservative activists are promoting ‘lies’ that Europe’s summer heatwaves are far from unusual
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-07-09-at-1.09.25-PM
Anti-vaccine myths rattle health care
Picture1
Hiroshima at 81: America’s new nuclear bomb, a buried Iranian target, and a question no one wants to ask
ChatGPT Image Jul 29, 2026, 12_05_21 PM
AI-generated physicians promoting bogus cures and worthless supplements surge on social media
ChatGPT Image Jul 29, 2026, 05_50_04 PM
Fear, science, and the law: If talc powder is unlikely to cause cancer and J&J was winning in court, why did it pay more than $5.5 billion to settle?
ChatGPT Image Jul 29, 2026, 06_26_01 PM 2
Facts & Fallacies podcast: Organic food myths make a comeback on Instagram, with Dr. Kevin Folta
ChatGPT Image Jul 29, 2026, 10_14_27 PM
After muzzling RFK, Jr. over autism-vaccine conspiracy theories, Trump defies aides to push scares again
Screenshot 2026-07-22 at 1.38
Viewpoint: Are the U.S. and Europe headed towards a repudiation of agricultural biotechnology red tape?

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.